Applying Ethics and Integrity to Human Research
IntegReview reviews the following types of research: Phase I-IV drug/biomedical, medical device, social and behavioral, Investigator-sponsored, single and multiple investigator as well as research conducted in academic and hospital settings, expedited review for research that qualifies, expedited review of additional Investigators, research determined to be exempt, International research and Canadian investigators.
facebook
IntegReview Ethical Review Board
3001 S. Lamar Blvd., Suite 210
Austin, TX 78704
Phone: 512-326-3001
Fax: 512-697-0085
Email:

IntegReview HIPAA Policy

Only sites determined to be a covered entity are responsible for complying with the Privacy Rule. Covered entities are health plans, health care clearinghouses, and health care providers that transmit health information electronically in connection with certain defined HIPAA transactions, such as claims or eligibility inquiries.

To obtain guidance on determining if your site is a covered entity or for information on the authorization elements, CLICK HERE.

If HIPAA language is integrated in the informed consent document IntegReview will review the content for confidentiality language and readability. Because IRBs are not required to comply with the Privacy Rule, IntegReview is not responsible for ensuring that the appropriate HIPAA requirements are included.

However, in the event you have a stand-alone HIPAA authorization, federal regulations do not require you to include this information in the informed consent document.

Additionally, federal regulations do not require IRBs to review and approve stand-alone HIPAA authorizations. The following is a website presenting the IRBs role under the Privacy Rule from the National Institutes of Health. Please refer to paragraph 12, which identifies IRB obligations regarding these stand-alone documents.

Should you have other questions or concerns regarding the IntegReview HIPAA Policy, please call us at 512-326-3001 or send us an email at integreview@integreview.com.